Boardroom Alpha
Boardroom Alpha
BAX · Additional Proxy Materials (DEFA14A) · Filed April 29, 2026

Baxter International Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 29, 2026
Ticker
BAX
Accession
0001193125-26-189237
Boardroom Alpha · Filing insights

Baxter backs charter amendment to shrink board to 7 and set 7-12 range; board urges voting FOR.

About Baxter International Inc
Market cap
$9.6B
1Y TSR
−40.1%
3Y TSR
−23.8%
Board grade
C-
Sector
Healthcare
CEO
Andrew P Hider
Last annual meeting: May 5, 2026 · View full Baxter International Inc profile →
DEFA14A
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

 

 

Filed by the Registrant ☑

Filed by a Party other than the Registrant ☐

CHECK THE APPROPRIATE BOX:

 

Preliminary Proxy Statement

 

Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Under Rule 14a-12

 

LOGO

Baxter International Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX):

 

No fee required.

 

Fee paid previously with preliminary materials:

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

April 29, 2026

 

 
 


Dear Fellow Stockholders,

We are writing today to request your support for our proposal to amend Baxter’s Certificate of Incorporation (Proposed Charter Amendment) to reduce the minimum number of directors from nine to seven and eliminate the maximum number of directors, with the exact number to be fixed from time to time by the Board. In response to investor feedback on this proposal, the Board has also adopted an amendment to the Company’s Bylaws (Bylaws Amendment), fixing the Board size within a range of seven to twelve members and retaining clear parameters consistent with prevailing governance practices. The Bylaws Amendment takes effect only if stockholders approve the Proposed Charter Amendment and is subject to its terms.

We believe the combination of the Proposed Charter Amendment and Bylaws Amendment creates a framework that provides the following benefits and is in the best interests of Baxter and its stockholders:

 

   

Flexible Framework: It preserves the Board’s ability to adjust its size as circumstances warrant while maintaining the optimal number of directors to facilitate effective decision making.

 

   

Supportive of Future Board Refreshment: It is intended to preserve flexibility for continuing Board refreshment and thoughtful succession planning, ensuring an optimal mix of skills, perspectives and experiences on the Board.

 

   

Clearly Defined Guardrails: It provides stockholders with assurance that any changes to Board size will continue to occur within clear and disciplined parameters, which the Board intends to maintain in the Bylaws until the next Charter amendment is approved by stockholders (at which time the related range would be moved to the Charter).

The Board reiterates its recommendation to vote “FOR” the Proposed Charter Amendment.

We encourage you to review the Proxy Statement and consider this supplemental information in connection with your vote at the Annual Meeting. If you have already voted Against the Proposed Charter Amendment, you may change your vote by following the instructions included in the Proxy Statement.

This Supplement should be read in conjunction with the Proxy Statement. Except as described above, this Supplement does not amend, supplement, or otherwise affect the Proxy Statement.

Thank you for your continued investment and support of Baxter International Inc.

 

Sincerely,

 

/s/ Brent Shafer

 

Brent Shafer
Non-Executive Chair of the Board
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Baxter International Inc (BAX)

Reference

Frequently asked questions

When did Baxter International Inc file this DEFA14A?
Baxter International Inc (BAX) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 29, 2026. The accession number assigned by EDGAR is 0001193125-26-189237.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Baxter backs charter amendment to shrink board to 7 and set 7-12 range; board urges voting FOR. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Baxter International Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Baxter International Inc has filed under CIK 10456, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer